Showing results (971-980 of 1,909) with videos related to
Sort By:
Pageof 191
Cardiology|November 1, 1996
Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsA Corsini, F Bernini, P Quarato, et al.Journal of Neurology|January 1, 1996
Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression?A Salmaggi, A Dufour, M Eoli, et al.Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|February 15, 2013
[Biological monitoring of exposure to carcinogenic metallic elements and polycyclic aromatic hydrocarbons in four secondary metallurgical sectors]G De Palma, A Corsini, E Gilberti, et al.Journal of Neurology|August 27, 1999
Immunological effects of in vivo interferon-beta1b treatment in ten patients with multiple sclerosis: a 1-year follow-upM Gelati, E Corsini, A Dufour, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 29, 2001
Twenty-four-hour endothelin-1 secretory pattern in stroke patientsR Franceschini, C Gandolfo, A Cataldi, et al.Archives of Neurology|May 22, 2002
Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosisMaurizio Gelati, Elena Corsini, Marco De Rossi, et al.Journal of Medicinal Chemistry|February 14, 2014
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: an appealing scaffold for the design of Rac1-Tiam1 protein-protein interaction inhibitorsAlessandro Ruffoni, Nicola Ferri, Sergio K Bernini, et al.International Journal of Pediatric Otorhinolaryngology|April 10, 2017
Management of orbital cellulitis and subperiosteal orbital abscess in pediatric patients: A ten-year reviewVittorio Sciarretta, Marco Demattè, Paolo Farneti, et al.Stem Cell Research|August 13, 2019
Reprogramming of Human Peripheral Blood Mononuclear Cell (PBMC) from a patient suffering of a Werner syndrome resulting in iPSC line (REGUi003-A) maintaining a short telomere lengthVincent Gatinois, Romain Desprat, Fabienne Becker, et al.Frontiers in Pharmacology|September 3, 2025
Therapeutic drug monitoring of selumetinib in pediatrics: a combined LC-MS/MS and LC-HRMS approachAlessia Cafaro, Andrea Santangelo, Sebastiano Barco, et al.Pageof 191